Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Full blood count, Metabolic function test
Clinical narrative: Dizziness and some cognitive 'confusion' or what I would describe as 'cognitive overlay' - dream like disconnected thoughts mixed cognitive awareness of them.  Not sure how else to describe it. and so; Dizziness and some cognitive 'confusion' or what I would describe as 'cognitive overlay' - dream like disconnected thoughts mixed cognitive awareness of them.  Not sure how else to describe it. and so; Dizziness and some cognitive 'confusion' or what I would describe as 'cognitive overlay' - dream like disconnected thoughts mixed cognitive awareness of them.  Not sure how else to describe it. and so; Dizziness and some cognitive 'confusion' or what I would describe as 'cognitive overlay' - dream like disconnected thoughts mixed cognitive awareness of them.  Not sure how else to describe it. and so; Dizziness and some cognitive 'confusion' or what I would describe as 'cognitive overlay' - dream like disconnected thoughts mixed cognitive awareness of them.  Not sure how else to describe it. and so; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP and Physician). The reporter is the patient.  A 64 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in deltoid left, administration date 18May2021 09:59 (Lot number: EW0173) at the age of 64 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "heart murmur (non-life threatening)" (unspecified if ongoing); "Lactose intollerance" (unspecified if ongoing); "gluten sensitivity" (unspecified if ongoing); "latent TB" (unspecified if ongoing); "Arthritis" (unspecified if ongoing), notes: 13 years; "vertigo intermittent" (unspecified if ongoing), notes: 14 years. The patient took concomitant medications. Past drug history included: Doxycycline, reaction(s): "allergies: doxycycline", notes: doxycycline; novacane; lactose intollerance; gluten sensitivity; Novacane, reaction(s): "allergies: novacane". Vaccination history included: Bnt162b2 (Dose: 1 st, Date (dd-Mmm-yyyy): 27Apr2021, Time (24hr): 12- 35 pm, Anatomical Site of injection: Left deltoid, Route of administration: Intramuscular, Lot number: EW0170, NDC no: 59267 -1000-1), administration date: 27Apr2021, when the patient was 64 years old, for COVID-19 immunisation. The following information was reported: AMNESIA (non-serious), DIZZINESS (non-serious), CONFUSIONAL STATE (non-serious), COGNITIVE DISORDER (non-serious), ABNORMAL DREAMS (non-serious) all with onset 26May2021, outcome "recovered" and all described as "Dizziness and some cognitive 'confusion' or what I would describe as 'cognitive overlay' - dream like disconnected thoughts mixed cognitive awareness of them.  Not sure how else to describe it. and so". The event "dizziness and some cognitive 'confusion' or what i would describe as 'cognitive overlay' - dream like disconnected thoughts mixed cognitive awareness of them.  not sure how else to describe it. and so", "dizziness and some cognitive 'confusion' or what i would describe as 'cognitive overlay' - dream like disconnected thoughts mixed cognitive awareness of them.  not sure how else to describe it. and so", "dizziness and some cognitive 'confusion' or what i would describe as 'cognitive overlay' - dream like disconnected thoughts mixed cognitive awareness of them.  not sure how else to describe it. and so", "dizziness and some cognitive 'confusion' or what i would describe as 'cognitive overlay' - dream like disconnected thoughts mixed cognitive awareness of them.  not sure how else to describe it. and so" and "dizziness and some cognitive 'confusion' or what i would describe as 'cognitive overlay' - dream like disconnected thoughts mixed cognitive awareness of them.  not sure how else to describe it. and so" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of amnesia, dizziness, confusional state, cognitive disorder, abnormal dreams.  Additional information: No other vaccine in four weeks. Patient administered daily multi vitamin medication in two weeks. No covid prior to vaccination. No COVID tested post vaccination. Dose 2 NDC no: 59267 -10001-1.  No follow-up attempts are possible. No further information is expected.